TP53 and pancreatic neoplasm: To assess the function of Smarcd3 in advanced pancreatic tumors driven by both RAS activation and p53 loss, we crossed Smarcd3f/f mice into two independent autochthonous models that enabled temporally distinct deletion of Smarcd3, either embryonically or in adult mice.